Hes1 attenuates type I IFN responses via VEGF-C and WDFY1

被引:16
|
作者
Ning, Fei [1 ,2 ,3 ,4 ]
Li, Xiaoyu [1 ,2 ,4 ]
Yu, Li [1 ,2 ,3 ,4 ]
Zhang, Bin [1 ,2 ,4 ]
Zhao, Yuna [5 ]
Liu, Yu [6 ]
Zhao, Baohong [7 ,8 ]
Shang, Yingli [5 ]
Hu, Xiaoyu [1 ,2 ,4 ]
机构
[1] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China
[2] Tsinghua Univ, Sch Med, Beijing, Peoples R China
[3] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China
[4] Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China
[5] Shandong Agr Univ, Coll Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China
[6] Wuhan Univ, Coll Life Sci, Med Res Inst, State Key Lab Virol, Wuhan, Hubei, Peoples R China
[7] Hosp Special Surg, Arthrit & Tissue Degenerat Program, David Z Rosensweig Genom Res Ctr, 535 E 70th St, New York, NY 10021 USA
[8] Weill Cornell Med Coll, Dept Med, New York, NY USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2019年 / 216卷 / 06期
基金
中国国家自然科学基金;
关键词
NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY; UP-REGULATION; INTERFERON; INFLAMMATION; DISEASE; ACTIVATION; NOTCH; INDUCTION;
D O I
10.1084/jem.20180861
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Induction of type I interferons (IFNs) is critical for eliciting competent immune responses, especially antiviral immunity. However, uncontrolled IFN production contributes to pathogenesis of autoimmune and inflammatory diseases. We found that transcription factor Hes1 suppressed production of type I IFNs and expression of IFN-stimulated genes. Functionally, Hes1-deficient mice displayed a heightened IFN signature in vivo, mounted enhanced resistance against encephalomyocarditis virus infection, and showed signs of exacerbated experimental lupus nephritis. Mechanistically, Hes1 did not suppress IFNs via direct transcriptional repression of IFN-encoding genes. Instead, Hes1 attenuated activation of TLR upstream signaling by inhibition of an adaptor molecule, WDFY1. Genome-wide assessment of Hes1 occupancy revealed that suppression of WDFY1 was secondary to direct binding and thus enhancement of expression of VEGF-C by Hes1, making Vegfc a rare example of an Hes1 positively regulated gene. In summary, these results identified Hes1 as a homeostatic negative regulator of type I IFNs for the maintenance of immune balance in the context of antiviral immunity and autoimmune diseases.
引用
收藏
页码:1396 / 1410
页数:15
相关论文
共 50 条
  • [31] Influenza a virus antagonizes type I and type II interferon responses via SOCS1-dependent ubiquitination and degradation of JAK1
    Du, Yinping
    Yang, Fan
    Wang, Qiuxia
    Xu, Nuo
    Xie, Yizhang
    Chen, Sujuan
    Qin, Tao
    Peng, Daxin
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [32] Functionally Distinct Effects of the C-Terminal Regions of IKKε and TBK1 on Type I IFN Production
    Nakatsu, Yuichiro
    Matsuoka, Mayumi
    Chang, Tsung-Hsien
    Otsuki, Noriyuki
    Noda, Masahiro
    Kimura, Hirokazu
    Sakai, Kouji
    Kato, Hiroshi
    Takeda, Makoto
    Kubota, Toru
    PLOS ONE, 2014, 9 (04):
  • [33] Induction of VEGF-C expression via mGluR5 in the lymph node metastases of oral cancer by the SDF-1/CXCR4 system
    Uchida, Daisuke
    Kuribayashi, Nobuyuki
    Tamatani, Tetsuya
    Nagai, Hirokazu
    Miyamoto, Youji
    CANCER RESEARCH, 2012, 72
  • [34] T-bet suppresses the IFN-gamma mediated induction of a T cell intrinsic type I IFN signature during T helper 1 responses
    Mikami, Yohei
    Davis, Fred
    Iwata, Shigeru
    Sun, Hong-Wei
    Stephen, Brooks R.
    Han-Yu, Shih
    Kawabe, Takeshi
    Jiang, Kan
    Jankovic, Dragana
    Sher, Alan
    Kanno, Yuka
    O'Shea, John J.
    CYTOKINE, 2017, 100 : 42 - 42
  • [35] PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway
    Hodgins, Jonathan J.
    Abou-Hamad, John
    O'Dwyer, Colin Edward
    Hagerman, Ash
    Yakubovich, Edward
    Tanese de Souza, Christiano
    Marotel, Marie
    Buchler, Ariel
    Fadel, Saleh
    Park, Maria M.
    Fong-McMaster, Claire
    Crupi, Mathieu F.
    Makinson, Olivia Joan
    Kurdieh, Reem
    Rezaei, Reza
    Dhillon, Harkirat Singh
    Ilkow, Carolina S.
    Bell, John C.
    Harper, Mary-Ellen
    Rotstein, Benjamin H.
    Auer, Rebecca C.
    Vanderhyden, Barbara C.
    Sabourin, Luc A.
    Bourgeois-Daigneault, Marie-Claude
    Cook, David P.
    Ardolino, Michele
    JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (07):
  • [36] The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways
    George, Parakkal Jovvian
    Marches, Radu
    Nehar-Belaid, Djamel
    Banchereau, Jacques
    Lustigman, Sara
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling
    Yeh, Yu-Wen
    Cheng, Ching-Chia
    Yang, Shu-Ting
    Tseng, Chi-Feng
    Chang, Ting-Yu
    Tsai, Sin-Ying
    Fu, Earl
    Chiang, Chien-Ping
    Liao, Li-Chuan
    Tsai, Pei-Wen
    Yu, Yung-Luen
    Su, Jen-Liang
    ONCOTARGET, 2017, 8 (03) : 5603 - 5618
  • [38] Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction
    David Shahnazaryan
    Rana Khalil
    Claire Wynne
    Caroline A. Jefferies
    Joan Ní Gabhann-Dromgoole
    Conor C. Murphy
    Scientific Reports, 10
  • [39] Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction
    Shahnazaryan, David
    Khalil, Rana
    Wynne, Claire
    Jefferies, Caroline A.
    Gabhann-Dromgoole, Joan Ni
    Murphy, Conor C.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [40] shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway
    Pan, Hong-Ming
    Lang, Wei-Ya
    Yao, Li-Jie
    Wang, Yan
    Li, Xiao-Ling
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (08) : 622 - 633